Founded in 1972, Eurofarma is one of the largest pharmaceutical companies in Brazil, Eurofarma stands out in the segments in which it operates. Voted as one of the 20 most innovative companies in Brazil, it recently launched in 2016 the 1st biosimilar medicine in Latin America.

The commitment and pursuit of innovation guide important milestones in the history of Eurofarma, as the launch of the first generic product for oncological use in Brazil in early 2000 and, shortly after, of generic oral and injectable contraceptives, ahead of the competition. In 2015, the company developed and obtained registration for the first biosimilar medication in Latin America.

Eurofarma believes in the broad development and always seeks economic, social and environmental balance. Water reuse, renewable energy, recycling, citizenship and education are some of the company's commitments.